Skip to main content
. 2022 Feb;76(1):72–74. doi: 10.5455/medarh.2022.76.72-74

Table 1. Summary of literature review of erythema nodosum following various COVID-19 Vaccine.

No. Country Age Interval Period Location of Rash Type of Vaccine Vaccine dose Reference
1 Taiwan 27 3 days Bilateral LL Medigen 1st dose (8)
2 Saudi Arabia 22 1 day Bilateral LL Pfizer 1st dose (9)
3 Morocco 66 2 days All 4 limbs Astrazeneca 2nd dose (10)
4 Italy 64 2 days Bilateral LL ChAdOx1-S nCoV-19 1st dose (11)